HPSE and plasma cell myeloma: Because our data indicate that heparanase promotes drug resistance of myeloma cells, we tested whether blocking heparanase enzyme activity using heparanase inhibitor, Roneparstat (Rone) would sensitize myeloma cells to chemotherapy.